Altimmune to Participate in the Wells Fargo 21st Annual Healthcare Conference
GAITHERSBURG, Md., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that management will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Thursday, September 10, 2026, at 9:30 a.m. ET.
Covered in this story
What has happened since
- Altimmune Inc is down 32.8% since this was published, 49 days ago.
- Wells Fargo is down 6.9% since this was published, 49 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $ALT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Altimmune Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.